<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03924076</url>
  </required_header>
  <id_info>
    <org_study_id>KE/FK/293/EC/2018</org_study_id>
    <nct_id>NCT03924076</nct_id>
  </id_info>
  <brief_title>Effect of Paraprobiotic Lactobacillus Plantarum IS-10506 on Humoral Immune Response of Elementary School Children</brief_title>
  <official_title>Effect of Paraprobiotic Lactobacillus Plantarum IS-10506 on Humoral Immune Response of Indonesian Elementary School Children: a Double Blind, Randomized, Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gadjah Mada University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gadjah Mada University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is aimed to determine effect of paraprobiotic Lactobacillus plantarum IS-10506 on
      humoral immune response by measuring faecal sIgA and blood IgG, IgM, and IgA
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The type of the study is double blind randomize placebo-controlled trial with minimum 72
      subjects which divided into 2 groups i.e. 1) placebo group which will receive UHT milk (125
      mL) and 2) treatment group which will received UHT milk + paraprobiotic Lactobacillus
      plantarum IS-10506 5 x 1010 CFU/day (125 mL). The subjects have to consume one pack of milk
      every day for 90 consecutive days. Before and after intervention (day 30 and day 90), several
      data will be collected i.e. faecal sIgA, blood IgG, IgM, and IgA. The subjects recruited from
      elementary school in Yogyakarta District.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 14, 2018</start_date>
  <completion_date type="Actual">April 4, 2019</completion_date>
  <primary_completion_date type="Actual">January 4, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum IgG</measure>
    <time_frame>90 days</time_frame>
    <description>Measuring IgG (ng/mL) in collected serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum IgA</measure>
    <time_frame>90 days</time_frame>
    <description>Measuring IgA (ng/mL) in collected serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum IgM</measure>
    <time_frame>90 days</time_frame>
    <description>Measuring IgM (ng/mL) in collected serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Faecal sIgA</measure>
    <time_frame>90 days</time_frame>
    <description>Measuring sIgA (ng/mL) in collected feses</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>90 days</time_frame>
    <description>Measuring weight (kg) change</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Height</measure>
    <time_frame>90 days</time_frame>
    <description>Measuring height (cm) change</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">79</enrollment>
  <condition>Humoral Immune Response</condition>
  <arm_group>
    <arm_group_label>Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Received UHT milk + paraprobiotic Lactobacillus plantarum IS-10506 5 x 1010 CFU/day (125 mL) for 90 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Received UHT milk (125 mL) for 90 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>UHT Milk + Lactobacillus plantarum IS-10506</intervention_name>
    <description>125 ml UHT milk (+Lactobacillus plantarum IS-10506) given to treatment group</description>
    <arm_group_label>Treatment Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>UHT Milk</intervention_name>
    <description>125 ml UHT milk given to placebo group</description>
    <arm_group_label>Placebo Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children at age of 7-9 years

          -  have normal body mass index (BMI) i.e. -2 â‰¤ z-score &lt; +1, slightly overweight z-score
             &lt; +1.5, and slightly underweight z-score &gt; -3.

        Exclusion Criteria:

          -  allergic to milk

          -  consuming other probiotic product

          -  he/she do not want to stop consumption &amp; doing washout for 2 weeks.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>9 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Siti Helmyati, DR.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gadjah Mada University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohammad Juffrie, Prof.dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gadjah Mada University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lily A Lestari, DR.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gadjah Mada University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitas Gadjah Mada</name>
      <address>
        <city>Sleman</city>
        <state>D.I.Yogyakarta</state>
        <zip>55281</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 16, 2019</study_first_submitted>
  <study_first_submitted_qc>April 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2019</study_first_posted>
  <last_update_submitted>April 22, 2019</last_update_submitted>
  <last_update_submitted_qc>April 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gadjah Mada University</investigator_affiliation>
    <investigator_full_name>DR.Siti Helmyati, DCN, M.Kes</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

